Related by context. All words. (Click for frequent words.) 69 biomarker identification 68 quantitative proteomics 68 proteomic analysis 67 somatic mutations 67 transcriptomes 67 molecular abnormalities 67 genomic alterations 66 DNA methylation patterns 66 differential gene expression 66 genomic biomarkers 66 immunoblot 66 microRNA biomarkers 66 Flow cytometry 66 molecular biomarkers 66 miRNA expression 66 chemosensitivity 66 Mass spectrometry 66 microRNA profiling 65 molecular biomarker 65 microarray gene expression 65 tumor biopsies 65 bisulfite sequencing 65 prognostic markers 65 druggable targets 65 kinase inhibition 65 murine models 65 quantitative PCR qPCR 65 tumorigenicity 65 DNA demethylation 65 splice variants 65 differentially expressed proteins 64 metabolite profiling 64 #S rRNA gene 64 metabolomic profiling 64 biomolecular interactions 64 transcriptomic 64 multiplex assay 64 gene rearrangements 64 gene amplification 64 gene expression assays 64 genomic proteomic 64 protein tyrosine phosphatase 64 multiplex assays 64 phenotypic traits 64 SiMoA 64 genomic profiling 64 p# biomarker 64 multiplex PCR 64 biomarker assays 64 Western blotting 64 phenotypic expression 64 bioassays 64 ELISAs 64 methylation markers 64 comparative genomic hybridization 64 CSHL scientists 64 prognostic biomarker 64 transgene expression 63 cell lysate 63 chromatin immunoprecipitation ChIP 63 multiplexed assays 63 chromosomal rearrangement 63 microRNA expression 63 enzyme kinetics 63 accurate quantitation 63 quantitative trait loci 63 miRNA profiling 63 metabolomic profiles 63 ligand binding 63 N glycan 63 quantitative PCR 63 GPx 63 antibody arrays 63 genomically 63 posttranslational modifications 63 AvalonRx R 63 Sanger Sequencing 63 immunofluorescent 63 sequence homology 63 mass spectrometric 63 #T# L1 63 functional annotation 63 monogenic 63 miRNA molecules 63 5 hmC 63 differentially expressed genes 63 K ras gene 63 silico prediction 63 Gene Ontology terms 62 p# INK4a 62 transcriptome analysis 62 ncRNA 62 proteomes 62 microwell plate 62 multiparametric 62 ELISA assay 62 genetic biomarkers 62 quantitative RT PCR 62 Corus CAD 62 tissue microarray 62 FFPE tissues 62 PCR primers 62 toxicogenomic 62 subcellular compartments 62 protein quantitation 62 molecular determinants 62 oligonucleotide microarray 62 genomic microarray 62 methylation patterns 62 RQ PCR 62 pharmacodynamic markers 62 comparative genomic 62 DNA methylation markers 62 linkage disequilibrium LD 62 plasma proteome 62 proteomic analyzes 62 immunohistochemical 62 cytotoxicity assays 62 immunohistochemistry IHC 62 vivo potency 62 inferential statistics 62 ChIP seq 62 Alternative splicing 62 UCOE 62 CellPort Technologies 62 prognostic indicators 62 PITX2 62 vitro assay 62 ChIP chip 62 RT qPCR 62 quantitation 62 TMPRSS2 ERG 62 Lymph node 62 genomic biomarker 62 MAPK pathway 62 kinase profiling 62 primate genomes 62 prognostically 62 non coding RNA 62 presymptomatic 62 immunohistochemical analysis 62 multigene 62 insertional mutagenesis 62 genomewide 62 pre malignant lesions 62 Nanobodies 62 molecular assays 62 CD# expression [001] 62 alpha fetoprotein AFP 61 biochemical marker 61 eTag assays 61 ABL1 61 ELISA assays 61 massively parallel sequencing 61 nucleated cells 61 biomarker validation 61 heterologous 61 substrate specificity 61 PET tracers 61 FGFR3 61 Nucleic acids 61 RRM1 61 modifier genes 61 BAC clones 61 QTL mapping 61 metagenomic sequencing 61 promoter methylation 61 KRAS mutation 61 miRNA biomarkers 61 virulence genes 61 Anticalins ® 61 hematopoietic progenitor cells 61 aCGH 61 mutational analysis 61 oligonucleotide microarrays 61 biomarker assay 61 genotyping assay 61 K RAS 61 proton MR spectroscopy 61 metabolomic 61 Cdc7 61 exome 61 delipidation 61 siRNA mediated 61 FSH receptor 61 diagnostic biomarker 61 transcriptome profiling 61 post translational modifications 61 immunostaining 61 splice variant 61 chromosome aberrations 61 oligonucleotide arrays 61 bioluminescent imaging 61 microarray analysis 61 fatty acid biosynthesis 61 optical biosensors 61 immunofluorescence microscopy 61 experimentally validated 61 phosphorylated proteins 61 cDNA microarray 61 array CGH 61 small molecule activators 61 cellular pathways 61 ZNF# 61 dosimetric 61 bacterial genomes 61 Drosophila genome 61 serologic tests 61 colorectal tumor 61 LNA TM 60 bronchial epithelial cells 60 HER2 expression 60 serum biomarkers 60 histone modifications 60 Microarray analysis 60 lymphoid cells 60 NPRL2 60 genotyping arrays 60 epithelial tumors 60 cyclin E 60 LC MALDI 60 biochemical assays 60 TMPRSS2 ERG fusion 60 radiolabeled 60 Htt 60 FDG-PET/CT 60 transgenic mouse models 60 DEAR1 60 pharmacophore 60 validate biomarkers 60 BioMAP 60 Tr DNA 60 immunoregulatory 60 phenotyping 60 hematopoietic progenitors 60 Aromatase 60 multi analyte 60 protein microarrays 60 suppressor gene 60 cDNA libraries 60 situ hybridisation 60 trophoblast cells 60 transcriptional profiling 60 SELDI TOF 60 beta1 integrin 60 Haptoglobin 60 miRview mets 60 TLE3 60 #S rRNA 60 gastric carcinomas 60 replicase 60 clonal expansion 60 xenobiotic 60 microsatellite instability 60 splice junctions 60 exome sequencing 60 microarray experiments 60 physico chemical properties 60 lysate 60 methylated DNA 60 T SPOT.TB 60 AttoSense 60 tyrosine phosphorylation 60 histopathologic 60 genetic loci 60 coexpression 60 PCR amplification 60 HER2 neu 60 cellularity 60 5 hydroxymethylcytosine 60 thymidylate synthase TS 60 dimensional nanostructures 60 pleiotropy 60 homology modeling 60 isotype 60 gamete formation 60 transfection efficiency 60 antibody antigen 60 phage display libraries 60 glycolipids 60 hepatocyte 60 HTRF R 60 prognostic biomarkers 60 comparative genomic analysis 60 HER2 overexpression 60 viral genomes 60 Ice COLD PCR 60 proteolytic cleavage 60 eIF 4E 60 S. maltophilia 60 RNA amplification 60 epigenomic 60 Sequencing Systems 60 IntroductionThe 60 transcriptomics proteomics 60 transcriptomics 60 synthetic peptides 60 immunofluorescence 60 RNA seq 60 paraffin embedded tissue 60 histone acetylation 60 coding genes 60 haplotyping 60 Affymetrix GeneChip 60 K ras 60 Oncotype 60 FDG PET scans 60 fungal genomes 60 transient transfection 60 Trofex 60 methylation profiling 60 Sanger sequencing 60 bioinformatic approaches 60 Clusterin 60 Molecular imaging 60 FDG PET imaging 60 adipogenic 60 molecular subtypes 60 2D electrophoresis 60 PrPSc 60 precursor lesions 60 preanalytical 60 #S rDNA 60 sDNA 60 drug metabolizing enzymes 60 conserved sequences 60 predictive biomarker 60 molecular profiling 60 cis regulatory 60 ChIP 60 quasispecies 60 MenSCs 60 synovial cells 60 nucleic acid sequence 60 antiangiogenic agent 60 #F FDG PET 60 flow cytometric 60 transfected cells 60 siRNA knockdown 60 lesional 60 PARP inhibition 59 Mass Spectrometry MS 59 prostate carcinomas 59 PIK3CA 59 Mutation Analysis 59 metaplasia 59 pharmacodynamic PD 59 electrophysiologic 59 serum antibodies 59 DLC1 59 enzymatic reactions 59 FISH fluorescence 59 Azedra 59 ELISpot 59 miRNA sequences 59 CCR1 59 Gleevec resistant 59 immunochemical 59 circulating endothelial cells 59 CpG island 59 Histologic 59 DGGE 59 haplotype map 59 biologic pathways 59 Fc gamma receptor 59 mTOR inhibitors 59 amplicon 59 ADME properties 59 Western Blotting 59 gene expression microarray 59 ELISA kit 59 immunogens 59 thymocyte 59 EML4 ALK 59 gDNA 59 immunoglobulin genes 59 Anticalins R 59 protein ligand 59 transgenic mice expressing 59 gene expression profiles 59 visuomotor 59 anti CD3 59 missense mutations 59 Deinococcus 59 transgenic rats 59 HIF 1α 59 breast epithelial cells 59 synthetic siRNAs 59 predictive biomarkers 59 Wnts 59 NSCLC tumors 59 immunosuppressive regimens 59 hybridoma 59 CHD5 59 aT cell 59 sRNA 59 protein tyrosine phosphatases 59 Histologically 59 HTS assay 59 prognostic indicator 59 combinatorial libraries 59 interferon lambda 59 immunoprecipitation 59 IGF IR 59 2D gel electrophoresis 59 Quantitation 59 HEK# cells 59 luciferase reporter 59 tumor antigen 59 CSF biomarkers 59 immunoblotting 59 multimodality imaging 59 short hairpin RNAs 59 biopsied tissue 59 lentiviral 59 nucleotide substitutions 59 evolvability 59 vivo assays 59 genomic markers 59 homodimers 59 mRNA transcripts 59 Mathematical modeling 59 hematopoietic cells 59 recombinants 59 aggregated Abeta 59 folate receptor 59 Pichia pastoris 59 Immunohistochemical 59 peptide antigens 59 prion infection 59 cellular prion protein 59 posttranslational modification 59 tumor hypoxia 59 reproducible measurements 59 diagnostic modality 59 histologic diagnosis 59 catalytically active 59 androgen receptor AR 59 bispecific antibody 59 prognostic marker 59 SELDI TOF MS 59 tumor subtypes 59 endpoint assays 59 K ras mutations 59 telomerase inhibitor 59 Confocal microscopy 59 EGFR receptor 59 genomewide association studies 59 miRview TM mets 59 secretory pathway 59 scintigraphic 59 anti angiogenic drugs 59 Rosetta Genomics microRNA 59 binding affinities 59 transcriptional regulation 59 nomograms 59 histopathological 59 noncoding RNAs 59 ENMD # 59 transgenic mouse model 59 HAAH 59 validating biomarkers 59 genome rearrangements 59 ALK mutations 59 qRT PCR 59 innate immune responses 59 MaxCyte STX 59 amplicons 59 proteomic biomarkers 59 HPV genotyping 59 breast cancer subtypes 59 phylogenetic analyzes 59 preoperative staging 59 florbetaben 59 formalin fixed paraffin embedded 59 glycomics 59 phenotypic variation 59 Phylogenetic analyzes 59 ultrastructural 59 4E BP1 59 lipid nanoparticles 59 mtDNA mutations 59 Annexin V 59 RNA polymerases 59 cyto 59 RNAi therapeutic targeting 59 MSn 59 osteoblastic 59 chromatin immunoprecipitation 59 ribosomal DNA 59 therapeutic radiopharmaceuticals 59 prostate carcinoma 59 isotypes 59 Alu elements 59 FGFs 59 paralogs 59 MALDI TOF MS 59 diagnostic prognostic 59 gene expression profiling 59 FLT3 59 affinity purification 59 APTIMA HPV 59 xenograft models 59 c myb 59 microRNAs miRNAs 59 MTT assay 59 radionuclide therapy 59 biomarker 59 fine needle aspiration 59 clonally 59 HLA genotyping 59 DNA Polymerase 59 haematopoietic 59 metabolic enzymes 59 carcinoids 59 pharmacologic intervention 59 mesenchymal stem cells MSCs 59 electrophysiological properties 59 kidney urologic 59 P cadherin 59 nano fluidic 58 eukaryotic genomes 58 lentiviral vectors 58 bioinformatic tools 58 clinicopathologic 58 gene rearrangement 58 OnDose TM 58 #S rRNA genes 58 SIRT1 activation 58 oligomeric 58 protein biosynthesis 58 preclinically 58 preclinical efficacy 58 metabolome 58 galectin 58 malignant nodules 58 kinase assay 58 M. pneumoniae 58 lymphatic mapping 58 SPECT CT imaging 58 AGHD 58 uPAR 58 NPM1 58 glycopeptides 58 Nanobodies ® 58 differentiate squamous 58 nucleic acid isolation 58 biorepositories 58 epigenetic markers 58 CD1d 58 H#K#me# 58 Single Nucleotide Polymorphism SNP 58 BRAF V#E mutation 58 mechanistic insight 58 TPMT 58 protein microarray 58 CyPath ® 58 ALK inhibitors 58 dAbs 58 cDNAs 58 RNA sequences 58 antibody mediated 58 serine threonine kinase 58 Immunohistochemical analysis 58 uncharacterized genes 58 protein conformation 58 Fc receptor 58 human leukocyte antigen HLA 58 noninvasive imaging 58 therapeutic modality 58 FFPE samples 58 proteomic technologies 58 kinome 58 embryonal 58 transcriptome sequencing 58 biophysical techniques 58 DNA methyltransferases 58 CD# ligand 58 GeneCards R 58 capillary electrophoresis CE 58 Mammostrat 58 biomarkers 58 radiolabeled antibodies 58 genotyping assays 58 Umbilical cord stem cells 58 intercellular signaling 58 ligand receptor 58 PTEN gene 58 genotyping gene expression 58 biosynthetic pathways 58 indolent lymphomas 58 renal tumors 58 immunofluorescence staining 58 mRNA expression 58 pharmacogenetic testing 58 multigenic 58 surface plasmon resonance SPR 58 ventricular myocardium 58 CPEB 58 Stat5 58 gene loci 58 Multiple logistic regression 58 kinase assays 58 mammary stem cells 58 malignant phenotype 58 outer membrane proteins 58 OGG1 58 HSPCs 58 biotransformation 58 CCX# 58 flavopiridol 58 Drosha 58 theranostic 58 genetic aberrations 58 BRAF inhibitors 58 membrane fusion 58 VEGF expression 58 Jhdm2a 58 endophenotypes 58 percutaneous biopsy 58 metabolite identification 58 Arabidopsis genes 58 ADAMTS# 58 Epigenomics proprietary 58 mechanistic insights 58 humoral responses 58 gene expression microarrays 58 p# Shc 58 structural rearrangements 58 microbiomes 58 pathologic examination 58 prostate cancer PCa 58 MALDI TOF 58 morphogen 58 hESC derived cardiomyocytes 58 breast carcinomas 58 BCR ABL mutations 58 proliferative disorders 58 ZFN 58 urothelial carcinoma 58 Affibody ® molecules 58 physicochemical properties 58 gastric adenocarcinoma 58 prostate epithelial cells 58 stratifying patients 58 HybSelect 58 ADAM# 58 perfusion imaging 58 chromosomal aberrations 58 ChIP Seq 58 Anticalin ® 58 thyroid carcinoma 58 CEACAM1 58 CHO K1 58 nucleolar 58 neoplastic transformation 58 Her2/neu 58 activating mutation 58 Array CGH 58 proteolytic activity 58 morphologic 58 histologies 58 PITX2 methylation 58 BiTE 58 colorimetric 58 ERK signaling 58 hypomethylation 58 3'UTR 58 Fluorescence microscopy 58 mechanistic studies 58 metastatic neuroendocrine tumors 58 PHD2 58 multiplex immunoassays 58 Xenopus embryos 58 morphometrics 58 carcinomatosis 58 tissue microarrays 58 semiquantitative 58 perfusion MRI 58 cytologic 58 intergenic 58 AGTR1 58 microtissues 58 antibody reagents 58 metabonomics 58 Membrane proteins 58 brightfield microscopy 58 transrectal ultrasound guided 58 extramedullary 58 chimeric protein 58 exosome 58 immunohistochemical staining 58 FGF signaling 58 mTOR inhibition 58 LungExpress Dx TM 58 epigenetic modification 58 QPCR 58 Methylation 58 p#INK#a 58 myelofibrosis polycythemia vera 58 zebrafish Danio rerio 58 fusion enhancers 58 iPS derived 58 inactivating mutations 58 mutated K ras 58 MiCK assay 58 immunomagnetic 58 MMP# 58 quantitative reverse transcriptase 58 lysates 58 benign neoplasms 58 Transcriptome 58 biospecimens 58 metabolite concentrations 58 pathogenic mutations 58 rxRNA 58 chromosomal mutations 58 vivo preclinical studies 58 antiproliferative effects 58 iPSC 58 nanocarrier 58 MGMT methylation 58 miRview ™ squamous 58 Bayesian statistical 58 recombinant antibodies 58 trait locus 58 P2V TM 58 effector function 58 PathFinderTG 58 enterotypes 58 gene expression patterns 58 Repeatability 58 NMR LipoProfile test 58 ligand induced 58 VSELs 58 endoglin 58 proline rich 58 immunochemical fecal occult 58 transcriptional regulators 58 PROCHYMAL 58 vascularisation 58 chromatin structure 58 microsatellite markers 58 Xanafide 58 chromosomal DNA 58 prognostic significance 58 bilayers 58 FUS1 58 osteoclast 58 microarray datasets 58 microRNA genes 58 gene locus 58 Nedd4 58 lymphangiogenesis 58 prognostic variables 57 antibiotic susceptibility 57 polyketides 57 epigenetic regulation 57 atherosclerosis regression 57 MT1 MMP 57 oxidative phosphorylation 57 Single Nucleotide Polymorphisms SNPs 57 oncogenic mutations 57 Upregulation 57 analyte 57 Cre recombinase 57 STK# [002] 57 genome annotation 57 IVIVC 57 endogenous ligands 57 PCA3 gene 57 tumor histology 57 granzyme B 57 hepatocellular carcinomas 57 p# activation 57 protein electrophoresis 57 HTRF 57 alternatively spliced 57 tumor specific antigen 57 KRAS oncogene 57 recursive partitioning 57 Spiegelmers 57 tumor suppressor protein 57 Genome sequencing 57 multipotent stem cells 57 DNA methylation biomarkers 57 mitochondrial gene 57 epithelial tissues 57 Prodarsan ® 57 ribosomal RNA rRNA 57 microdeletions 57 histone deacetylase inhibitor 57 reaction RT PCR 57 urine cytology 57 enzyme cofactor 57 STK# gene 57 AlloMap 57 underlying pathophysiology 57 immunological responses 57 acinar 57 Estrogen Receptor 57 ELISPOT assay 57 Protein Kinase C 57 protein kinase inhibitor 57 Raman spectra 57 histocompatibility 57 catalytic antibodies 57 glycolytic 57 molecular diagnostic assays 57 metazoan 57 PPARγ 57 PI3K AKT 57 coding exons 57 transcriptional activation 57 shotgun sequencing 57 adenoviral 57 pretargeting 57 extracellular proteins 57 CXCR4 expression 57 CDX2 57 anticancer therapeutics 57 gene expression biomarkers 57 reaction PCR 57 pharmacologic approaches 57 TLR antagonist 57 plasma kallikrein 57 genotypic 57 bacterial virulence 57 vascular disrupting agents 57 DNA rearrangements 57 trans splicing 57 PKCi 57 SNP genotyping 57 perilipin 57 cellular immunotherapy 57 bioinformatic analyzes 57 siRNAs targeting 57 hESC derived cells 57 Immunohistochemical staining 57 powder diffraction 57 pleiotropic effects 57 pathophysiological mechanisms 57 pyrosequencing 57 histone modification 57 aneuploid cells 57 APOE genotype 57 epistatic 57 post transcriptional 57 cMET 57 p# MAPK 57 TaqMan assays 57 penetrance 57 redox active 57 interferon γ 57 immune modulating 57 causative genes 57 RNA Seq 57 β catenin 57 pancreatic ductal 57 CardioPET 57 NPM1 mutation 57 polyclonal 57 nucleases 57 #beta HSD1 57 liver metastasis 57 etiologic agent 57 murine model 57 antiangiogenic therapy 57 rRNA 57 genes differentially expressed 57 LungExpress Dx 57 vimentin 57 COLD PCR 57 quantitate 57 infectious prion proteins 57 MALAT1 57 pancreatic cysts 57 passaging 57 qNPA 57 deacetylase 57 recombinant albumin 57 DHPLC 57 heterogeneous catalysts 57 deCODE BreastCancer TM 57 parthenogenetic stem cells 57 alkaline phosphatase ALP 57 subcellular localization 57 pleural fluid 57 Prognostic factors 57 soluble proteins 57 biochemical abnormalities 57 NS5A 57 Mesenchymal 57 soluble CD# ligand 57 physiologically relevant 57 Activity Assay 57 anti angiogenic therapy 57 activin 57 antisense inhibitors 57 NR2B subunit 57 microvessel 57 myeloproliferative diseases 57 tumor antigens 57 uricase 57 microinjection 57 CINtec R 57 hENT1 57 histone deacetylase HDAC 57 previously uncharacterized 57 Akt activation 57 MALDI imaging 57 hES cells 57 oncoproteins 57 patterning technique 57 Bayesian inference 57 Skeletal muscle 57 homozygote 57 NGAL 57 C. difficile toxins 57 PBMCs 57 Notch signaling pathway 57 diagnostic assays 57 viral antigens 57 ALDH br cells 57 VeraCode 57 osteoid 57 Hedgehog inhibitor 57 glycosylated 57 pharmacodynamic biomarkers 57 p# antigen 57 cytoskeletal structure 57 retroviral vector 57 toxicogenomics 57 monoclonals 57 shRNAs 57 bone scintigraphy 57 transferrin receptor 57 affinity antibodies 57 unicellular organism 57 nucleosome positioning 57 HepDirect prodrug 57 histologic subtypes 57 mitochondrial proteins 57 ColoMarker 57 sequenced genomes 57 anti androgens 57 causal variants 57 engineered RAP peptides 57 5alpha reductase 57 epigenetic therapeutics 57 KineMarker TM 57 quantitative gene expression 57 LRP5 57 radiosensitivity 57 Chronic pancreatitis 57 antitumour 57 CupPrint 57 histological subtype 57 genotype phenotype 57 busulfan 57 IgG1 antibodies 57 etiologic 57 subunit vaccine 57 Infinium assay 57 STAT4 57 glycan 57 cAMP signaling 57 KRAS status 57 FGFR1 57 peptide inhibitors 57 patient subpopulations 57 clinicopathological 57 enzymatic pathways 57 Leydig cells 57 ImmuneY2 57 cisplatin resistant 57 nCounter 57 Induced pluripotent stem cells 57 RKIP 57 iTRAQ 57 aberrant methylation 57 PCR assays 57 cerebrospinal fluid CSF 57 prostatic tissue 57 affinity ligands 57 microdroplet based 57 CXCR4 receptor 57 P. patens 57 intergenic regions 57 B7 H4 57 plexiform 57 proteome 57 HeliScope Sequencer 57 mass spectrometry MS 57 KLF4 57 thyroglobulin 57 rxRNA compounds 57 siRNA therapeutic 57 filamentous fungi